MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

29.21 +0.84 (+2.96%)
Official Closing Price Updated: 4:10 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
News headline image
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
From Pfizer Inc.
Via Business Wire
News headline image
Avident Health and Unite for HER Awarded Quality Improvement Grant from Pfizer and the National Comprehensive Cancer Network® (NCCN®) to Support Metastatic Breast Cancer Patients
October 8, 2026 -- Initiative leverages the MyNavigator™ digital care coordination platform to translate NCCN Guidelines® into actionable home-based education, expand access to integrative oncology... 
Via 24-7 Press Release
News headline image
Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Declares Fourth-Quarter 2026 Dividend
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
From Pfizer Inc
Via Business Wire
News headline image
Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:GILD),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
A Growing Global Threat From Emerging Viruses Is Fueling Urgent Demand For New Treatments And Creating A Potentially Massive Market For Innovative Antiviral Developers 
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
2025 R&D Spending And Intensity Benchmarks
Via PRLog
Topics Supply Chain
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
From Pfizer Inc.
Via Business Wire
News headline image
What Health Experts Want You to Know About Pneumococcal Pneumonia
Via StatePoint Media
News headline image
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
From Pfizer Inc.
Via Business Wire
News headline image
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer
From Pfizer Inc.
Via Business Wire
News headline image
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
From Pfizer Inc.
Via Business Wire
News headline image
OS Therapies Appoints Dr. Craig Eagle to Board of Directors
Company secures $10 million line of credit supported by OS Therapies UK tax creditsNew York, New York and Rockville, Maryland--(Newsfile... 
Via Newsfile
News headline image
Pfizer Declares Third-Quarter 2026 Dividend
From Pfizer Inc.
Via Business Wire
News headline image
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
From Pfizer Inc.
Via Business Wire
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
Via Investor Brand Network
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
From BioMedWire
Via GlobeNewswire
News headline image
Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Chief Financial Officer Transition
From Pfizer Inc.
Via Business Wire
News headline image
Consumer Watchdog Honors Michael A. Kelly with 2026 Lifetime Legal Achievement Award
June 17, 2026 -- The award recognizes distinguished attorneys and public-interest advocates whose careers have advanced consumer protection, challenged corporate misconduct, and improved public... 
Via 24-7 Press Release
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story